Contrasting the Influence of Cationic Amino Acids on the Viscosity and Stability of a Highly Concentrated Monoclonal Antibody

被引:54
作者
Dear, Barton J. [1 ]
Hung, Jessica J. [1 ]
Truskett, Thomas M. [1 ]
Johnston, Keith P. [1 ]
机构
[1] Univ Texas Austin, McKetta Dept Chem Engn, Austin, TX 78712 USA
基金
美国国家科学基金会;
关键词
antibody; arginine; histidine; rheology; viscosity; REVERSIBLE SELF-ASSOCIATION; MODELING PROTEIN STABILITY; COARSE-GRAINED STRATEGY; CLUSTER FORMATION; ARGININE; HISTIDINE; FORMULATIONS; DISPERSIONS; CHALLENGES; MECHANISM;
D O I
10.1007/s11095-016-2055-5
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
To explain the effects of cationic amino acids and other co-solutes on the viscosity, stability and protein-protein interactions (PPI) of highly concentrated (>= 200 mg/ml) monoclonal antibody (mAb) solutions to advance subcutaneous injection. The viscosities of >= 200 mg/ml mAb1 solutions with various co-solutes and pH were measured by capillary rheometry in some cases up to 70,000 s(-1). The viscosities are analyzed in terms of dilute PPI characterized by diffusion interaction parameters (k(D)) from dynamic light scattering (DLS). MAb stability was measured by turbidity and size exclusion chromatography (SEC) after 4 weeks of 40 degrees C storage. Viscosity reductions were achieved by reducing the pH, or adding histidine, arginine, imidazole or camphorsulfonic acid, each of which contains a hydrophobic moiety. The addition of inorganic electrolytes or neutral osmolytes only weakly affected viscosity. Systems with reduced viscosities also tended to be Newtonian, while more viscous systems were shear thinning. Viscosity reduction down to 20 cP at 220 mg/ml mAb1 was achieved with co-solutes that are both charged and contain a hydrophobic interaction domain for sufficient binding to the protein surface. These reductions are related to the DLS diffusion interaction parameter, k(D), only after normalization to remove the effect of charge screening. Shear rate profiles demonstrate that select co-solutes reduce protein network formation.
引用
收藏
页码:193 / 207
页数:15
相关论文
共 53 条
[1]   Rheological characterization and injection forces of concentrated protein formulations: An alternative predictive model for non-Newtonian solutions [J].
Allmendinger, Andrea ;
Fischer, Stefan ;
Huwyler, Berg ;
Mahler, Hanns-Christian ;
Schwarb, Edward ;
Zarraga, Isidro E. ;
Mueller, Robert .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2014, 87 (02) :318-328
[2]   THE STABILIZATION OF PROTEINS BY OSMOLYTES [J].
ARAKAWA, T ;
TIMASHEFF, SN .
BIOPHYSICAL JOURNAL, 1985, 47 (03) :411-414
[3]   Suppression of protein interactions by arginine: A proposed mechanism of the arginine effects [J].
Arakawa, Tsutomu ;
Ejima, Daisuke ;
Tsumoto, Kouhei ;
Obeyama, Noriyuki ;
Tanaka, Yoshikazu ;
Kita, Yoshiko ;
Timasheff, Serge N. .
BIOPHYSICAL CHEMISTRY, 2007, 127 (1-2) :1-8
[4]   Intermolecular Interactions and the Viscosity of Highly Concentrated Monoclonal Antibody Solutions [J].
Binabaji, Elaheh ;
Ma, Junfen ;
Zydney, Andrew L. .
PHARMACEUTICAL RESEARCH, 2015, 32 (09) :3102-3109
[5]   Viscosity Reduction of a Concentrated Monoclonal Antibody with Arginine•ICI and Arginin•Glutamate [J].
Borwankar, Ameya U. ;
Dear, Barton J. ;
Twu, April ;
Hung, Jessica J. ;
Dinin, Aileen K. ;
Wilson, Brian K. ;
Yue, Jingyan ;
Maynard, Jennifer A. ;
Truskett, Thomas M. ;
Johnston, Keith P. .
INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH, 2016, 55 (43) :11225-11234
[6]   Tunable equilibrium nanocluster dispersions at high protein concentrations [J].
Borwankar, Ameya U. ;
Dinin, Aileen K. ;
Laber, Joshua R. ;
Twu, April ;
Wilson, Brian K. ;
Maynard, Jennifer A. ;
Truskett, Thomas M. ;
Johnston, Keith P. .
SOFT MATTER, 2013, 9 (06) :1766-1771
[7]   Highly Viscous Antibody Solutions Are a Consequence of Network Formation Caused by Domain-Domain Electrostatic Complementarities: Insights from Coarse-Grained Simulations [J].
Buck, Patrick M. ;
Chaudhri, Anuj ;
Kumar, Sandeep ;
Singh, Satish K. .
MOLECULAR PHARMACEUTICS, 2015, 12 (01) :127-139
[8]   Rheological and syringeability properties of highly concentrated human polyclonal immunoglobulin solutions [J].
Burckbuchler, V. ;
Mekhloufi, G. ;
Giteau, A. Paillard ;
Grossiord, J. L. ;
Huille, S. ;
Agnely, F. .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2010, 76 (03) :351-356
[9]   Overlooking Subvisible Particles in Therapeutic Protein Products: Gaps That May Compromise Product Quality [J].
Carpenter, John F. ;
Randolph, Theodore W. ;
Jiskoot, Wim ;
Crommelin, Daan J. A. ;
Middaugh, C. Russell ;
Winter, Gerhard ;
Fan, Ying-Xin ;
Kirshner, Susan ;
Verthelyi, Daniela ;
Kozlowski, Steven ;
Clouse, Kathleen A. ;
Swann, Patrick G. ;
Rosenberg, Amy ;
Cherney, Barry .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 98 (04) :1201-1205
[10]   Potent antibody therapeutics by design [J].
Carter, PJ .
NATURE REVIEWS IMMUNOLOGY, 2006, 6 (05) :343-357